The future of rare diseases and orphan drugs

 

World Orphan Drug Congress 2015

  • Discuss pressing issues such as the pricing and reimbursement debate, commercialisation challenges and engaging with patients during research and development of new therapies.
     
  • Meet and interact with representatives from pharma, biotechs, payers, government, regulators, academia and patient groups.
     
  • Use extended networking time to seek out and build partnerships to speed up the development of orphan drugs. 
     
  • Network with attendees of our co-located World Gene Therapy Congress. 

DOWNLOAD THE PRE-BROCHURE

 

Should you sponsor?

Why get involved?

Find out more about how you can promote your products at the orphan drug sector’s premier event by downloading the sponsorship brochure today. 

"WODC is the key annual congress for anybody working in the rare disease arena.”
Oxford PharmaGenesis

Why sponsor?

  • Speak to a room full of orphan drug experts
  • Host a roundtable and meet your customers
  • Let us organise 1-2-1 meetings for you
  • Let us generate sales leads pre-event
  • Take a private meeting room

Why exhibit?

  • Show off your latest products & innovations
  • Promote new services
  • Educate your target market
  • Generate new sales leads
  • Raise brand profile

GET THE PROSPECTUS

Sponsor & Exhibitors

 

  • Supporting Partner

    GlaxoSmithKline at World Orphan Drug Congress

    Gold Sponsor

    Shire Human Genetic Therapies at World Orphan Drug Congress
  • Gold Sponsor

    Premier Research at World Orphan Drug Congress

    Gold Sponsor

    Pfizer at World Orphan Drug Congress
  • Gold Sponsor

    MAPI at World Orphan Drug Congress

    Gold Sponsor

    PTC Therapeutics at World Orphan Drug Congress
  • Gold Sponsor

    Quintiles at World Orphan Drug Congress

    Gold Sponsor

    Clinigen Group at World Orphan Drug Congress
  • Silver Sponsor

    Alliance Life Sciences at World Orphan Drug Congress

    Bronze Sponsor

    Pharma Price International at World Orphan Drug Congress
  • Bronze Sponsor

    Durbin Plc at World Orphan Drug Congress

    Bronze Sponsor

    Genpharm at World Orphan Drug Congress
  • Bronze Sponsor

    Voisin Consulting Life Sciences at World Orphan Drug Congress

    Bronze Sponsor

    Ergomed at World Orphan Drug Congress
  • Company Showcase Sponsor

    BioBlast Pharma Ltd at World Orphan Drug Congress

    Exhibitor

    APL at World Orphan Drug Congress
  • Exhibitor

    Clear Pharma at World Orphan Drug Congress

    Exhibitor

    Comradis at World Orphan Drug Congress
  • Exhibitor

    Cote Orphan at World Orphan Drug Congress

    Exhibitor

    Orphan Reach at World Orphan Drug Congress
  • Exhibitor

    Oxford PharmaGenesis at World Orphan Drug Congress

    Exhibitor

    P.P.D. at World Orphan Drug Congress
  • Exhibitor

    PSR-Agility Orphan Drug Development at World Orphan Drug Congress

JOIN THEM

Be part of the conversation

 

ZoharArgovPresImage

“Developing a mutant protein-stabilizing platform based on a small molecule for orphan diseases”

Zohar Argov of BioBlast Pharma  joined us for World Orphan Drug Congress USA 2015 to present about ‘ Developing a mutant protein-stabilizing platform based on a small ...

The post “Developing a mutant protein-stabilizing platform based on a small molecule for orphan diseases” appeared first on Orphan Drugs.

DerekKalaitaPresImage

“Engineering Biotechnology for the Brain”

Derek Kalaita of ArmaGen  joined us for World Orphan Drug Congress USA 2015 to present about ‘ Engineering Biotechnology for the Brain’   Download his presentation now to ...

The post “Engineering Biotechnology for the Brain” appeared first on Orphan Drugs.

ChristopherMisslingPresImage

“Potential Applications of Sigma-1 Receptors in Orphan Indications: Spinocerebellar Ataxia (SCA)”

Christopher Missling of Anavex Life Sciences Corp.  joined us for World Orphan Drug Congress USA 2015 to present about ‘ Potential Applications of Sigma-1 Receptors in Orphan ...

The post “Potential Applications of Sigma-1 Receptors in Orphan Indications: Spinocerebellar Ataxia (SCA)” appeared first on Orphan Drugs.

Join the Community

Strategy and innovation for the orphan drug and rare disease industry

Sign Up to Our Newsletter